rs201238819

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1

The NM_001009944.3(PKD1):​c.8087T>G​(p.Leu2696Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L2696F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 20)
Exomes 𝑓: 0.00041 ( 1 hom. )
Failed GnomAD Quality Control

Consequence

PKD1
NM_001009944.3 missense

Scores

19

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.659

Publications

12 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0077767074).
BP6
Variant 16-2104572-A-C is Benign according to our data. Variant chr16-2104572-A-C is described in ClinVar as Likely_benign. ClinVar VariationId is 433983.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0015 (219/145524) while in subpopulation AMR AF = 0.00388 (57/14680). AF 95% confidence interval is 0.00308. There are 0 homozygotes in GnomAd4. There are 107 alleles in the male GnomAd4 subpopulation. Median coverage is 20. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.8087T>G p.Leu2696Arg missense_variant Exon 22 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.8087T>G p.Leu2696Arg missense_variant Exon 22 of 46 1 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.00150
AC:
218
AN:
145412
Hom.:
0
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.00187
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00389
Gnomad ASJ
AF:
0.00178
Gnomad EAS
AF:
0.000846
Gnomad SAS
AF:
0.00133
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00100
Gnomad OTH
AF:
0.00300
GnomAD2 exomes
AF:
0.00108
AC:
184
AN:
170576
AF XY:
0.00112
show subpopulations
Gnomad AFR exome
AF:
0.00167
Gnomad AMR exome
AF:
0.00203
Gnomad ASJ exome
AF:
0.00245
Gnomad EAS exome
AF:
0.000145
Gnomad FIN exome
AF:
0.000160
Gnomad NFE exome
AF:
0.000886
Gnomad OTH exome
AF:
0.00194
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000412
AC:
596
AN:
1447962
Hom.:
1
Cov.:
30
AF XY:
0.000417
AC XY:
300
AN XY:
720112
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00145
AC:
48
AN:
33218
American (AMR)
AF:
0.00174
AC:
77
AN:
44198
Ashkenazi Jewish (ASJ)
AF:
0.000734
AC:
19
AN:
25892
East Asian (EAS)
AF:
0.00134
AC:
53
AN:
39480
South Asian (SAS)
AF:
0.000341
AC:
29
AN:
85014
European-Finnish (FIN)
AF:
0.0000793
AC:
4
AN:
50416
Middle Eastern (MID)
AF:
0.000729
AC:
3
AN:
4116
European-Non Finnish (NFE)
AF:
0.000301
AC:
333
AN:
1105806
Other (OTH)
AF:
0.000501
AC:
30
AN:
59822
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.349
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00150
AC:
219
AN:
145524
Hom.:
0
Cov.:
20
AF XY:
0.00151
AC XY:
107
AN XY:
70886
show subpopulations
African (AFR)
AF:
0.00189
AC:
74
AN:
39180
American (AMR)
AF:
0.00388
AC:
57
AN:
14680
Ashkenazi Jewish (ASJ)
AF:
0.00178
AC:
6
AN:
3362
East Asian (EAS)
AF:
0.000848
AC:
4
AN:
4718
South Asian (SAS)
AF:
0.00133
AC:
6
AN:
4524
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10178
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
278
European-Non Finnish (NFE)
AF:
0.00100
AC:
66
AN:
65720
Other (OTH)
AF:
0.00297
AC:
6
AN:
2018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000692
Hom.:
0
ExAC
AF:
0.000474
AC:
54

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKD1 p.Leu2696Arg variant was identified in 14 of 286 proband chromosomes (frequency: 0.049) from individuals or families with ADPKD, and was not identified in 100 control chromosomes from healthy individuals (Phakdeekitcharoen 2001, Bataille 2011, Yu 2011). The p.Leu2696Arg variant was identified in the dbSNP (ID: rs201238819) with no known clinical significance. The variant was not identified in NHLBI Exome Sequencing Project (Exome Variant Server). The variant was identified in Exome Aggregation Consortium (March 14, 2016), in 42 of 19230 chromosomes (frequency: 0.002) or 10 of 8070 South Asians, 24 of 7400 European (Non-Finnish), 2 of 628 Latino, 5 of 1616 African and 1 of 178 Other populations and not found in East Asian and European (Finnish), increasing the likelihood this could be a low frequency benign variant. The variant was identified in the PKD Mutation Database and was classified as likely neutral. The p.Leu2696 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein. However, this information is not predictive enough to rule out pathogenicity. In a study of 41 Thai probands with ADPKD and pathogenic variants in the replicated portion of the PKD1 gene, the p.Leu2696Arg variant was identified to occur in non-conservative region within the REJ domain, but its effect on the three-dimensional structure is unknown. Glutamic acid and arginine are observed in the corresponding positions of Fugu and murine polycystin-1, respectively, suggesting a noncritical role for a nonpolar residue at this location (Phakdeekitcharoen 2001). In ADPKD family studies, the variant was identified in a fetus with cystic kidneys resembling ADPKD on ultrasound however it co-occurred with a de novo PKD1 “likely pathogenic” variant (c.9222C>G, p.Asn3074Lys. The fetus was also identified to carry a HNF1β “highly likely pathogenic” variant (c.883C>T, p.Arg295Cys) which was also identified in the father and paternal grandmother who had cystic kidneys consistent with the HNF1β phenotype. The PKD1 p.Leu2696Arg variant was inherited from the mother with a normal renal phenotype. (Bergmann_2011_22034641). In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as Benign. -

not provided Benign:1
Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PKD1: BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.043
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
4.7
DANN
Benign
0.57
DEOGEN2
Benign
0.13
T;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.044
T;T
M_CAP
Benign
0.051
D
MetaRNN
Benign
0.0078
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-2.2
N;N
PhyloP100
0.66
PrimateAI
Benign
0.43
T
PROVEAN
Benign
2.1
N;N
REVEL
Benign
0.25
Sift
Benign
0.89
T;T
Sift4G
Benign
0.93
T;T
Polyphen
0.0
B;B
Vest4
0.16
MVP
0.76
ClinPred
0.00030
T
GERP RS
-1.7
Varity_R
0.055
gMVP
0.16
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201238819; hg19: chr16-2154573; COSMIC: COSV51910409; COSMIC: COSV51910409; API